Literature DB >> 25614629

Dynamic regulation of Schwann cell enhancers after peripheral nerve injury.

Holly A Hung1, Guannan Sun2, Sunduz Keles2, John Svaren3.   

Abstract

Myelination of the peripheral nervous system is required for axonal function and long term stability. After peripheral nerve injury, Schwann cells transition from axon myelination to a demyelinated state that supports neuronal survival and ultimately remyelination of axons. Reprogramming of gene expression patterns during development and injury responses is shaped by the actions of distal regulatory elements that integrate the actions of multiple transcription factors. We used ChIP-seq to measure changes in histone H3K27 acetylation, a mark of active enhancers, to identify enhancers in myelinating rat peripheral nerve and their dynamics after demyelinating nerve injury. Analysis of injury-induced enhancers identified enriched motifs for c-Jun, a transcription factor required for Schwann cells to support nerve regeneration. We identify a c-Jun-bound enhancer in the gene for Runx2, a transcription factor induced after nerve injury, and we show that Runx2 is required for activation of other induced genes. In contrast, enhancers that lose H3K27ac after nerve injury are enriched for binding sites of the Sox10 and early growth response 2 (Egr2/Krox20) transcription factors, which are critical determinants of Schwann cell differentiation. Egr2 expression is lost after nerve injury, and many Egr2-binding sites lose H3K27ac after nerve injury. However, the majority of Egr2-bound enhancers retain H3K27ac, indicating that other transcription factors maintain active enhancer status after nerve injury. The global epigenomic changes in H3K27ac deposition pinpoint dynamic changes in enhancers that mediate the effects of transcription factors that control Schwann cell myelination and peripheral nervous system responses to nerve injury.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ChIP Sequencing (ChIP-seq); Chromatin Immunoprecipitation (ChiP); Glial Cell; Histone Modification; Neurobiology; Schwann Cells

Mesh:

Substances:

Year:  2015        PMID: 25614629      PMCID: PMC4358118          DOI: 10.1074/jbc.M114.622878

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  93 in total

1.  Transcriptional profiling of the injured sciatic nerve of mice carrying the Wld(S) mutant gene: identification of genes involved in neuroprotection, neuroinflammation, and nerve regeneration.

Authors:  Benoit Barrette; Ezéquiel Calvo; Nicolas Vallières; Steve Lacroix
Journal:  Brain Behav Immun       Date:  2010-08-03       Impact factor: 7.217

2.  Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10.

Authors:  N Bondurand; M Girard; V Pingault; N Lemort; O Dubourg; M Goossens
Journal:  Hum Mol Genet       Date:  2001-11-15       Impact factor: 6.150

3.  Regulation of the PMP22 gene through an intronic enhancer.

Authors:  Erin A Jones; Camila Lopez-Anido; Rajini Srinivasan; Courtney Krueger; Li-Wei Chang; Rakesh Nagarajan; John Svaren
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

4.  HDAC1 and HDAC2 control the transcriptional program of myelination and the survival of Schwann cells.

Authors:  Claire Jacob; Carlos N Christen; Jorge A Pereira; Christian Somandin; Arianna Baggiolini; Pirmin Lötscher; Murat Ozçelik; Nicolas Tricaud; Dies Meijer; Teppei Yamaguchi; Patrick Matthias; Ueli Suter
Journal:  Nat Neurosci       Date:  2011-03-20       Impact factor: 24.884

Review 5.  Modification of enhancer chromatin: what, how, and why?

Authors:  Eliezer Calo; Joanna Wysocka
Journal:  Mol Cell       Date:  2013-03-07       Impact factor: 17.970

6.  Architecture of the human regulatory network derived from ENCODE data.

Authors:  Mark B Gerstein; Anshul Kundaje; Manoj Hariharan; Stephen G Landt; Koon-Kiu Yan; Chao Cheng; Xinmeng Jasmine Mu; Ekta Khurana; Joel Rozowsky; Roger Alexander; Renqiang Min; Pedro Alves; Alexej Abyzov; Nick Addleman; Nitin Bhardwaj; Alan P Boyle; Philip Cayting; Alexandra Charos; David Z Chen; Yong Cheng; Declan Clarke; Catharine Eastman; Ghia Euskirchen; Seth Frietze; Yao Fu; Jason Gertz; Fabian Grubert; Arif Harmanci; Preti Jain; Maya Kasowski; Phil Lacroute; Jing Jane Leng; Jin Lian; Hannah Monahan; Henriette O'Geen; Zhengqing Ouyang; E Christopher Partridge; Dorrelyn Patacsil; Florencia Pauli; Debasish Raha; Lucia Ramirez; Timothy E Reddy; Brian Reed; Minyi Shi; Teri Slifer; Jing Wang; Linfeng Wu; Xinqiong Yang; Kevin Y Yip; Gili Zilberman-Schapira; Serafim Batzoglou; Arend Sidow; Peggy J Farnham; Richard M Myers; Sherman M Weissman; Michael Snyder
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962

7.  In vivo detection of Egr2 binding to target genes during peripheral nerve myelination.

Authors:  Sung-Wook Jang; Scott E LeBlanc; Avtar Roopra; Lawrence Wrabetz; John Svaren
Journal:  J Neurochem       Date:  2006-09       Impact factor: 5.372

8.  Linking disease associations with regulatory information in the human genome.

Authors:  Marc A Schaub; Alan P Boyle; Anshul Kundaje; Serafim Batzoglou; Michael Snyder
Journal:  Genome Res       Date:  2012-09       Impact factor: 9.043

9.  Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase.

Authors:  Isabel Serrano; Paul C McDonald; Frances Lock; William J Muller; Shoukat Dedhar
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Krox-20 controls myelination in the peripheral nervous system.

Authors:  P Topilko; S Schneider-Maunoury; G Levi; A Baron-Van Evercooren; A B Chennoufi; T Seitanidou; C Babinet; P Charnay
Journal:  Nature       Date:  1994-10-27       Impact factor: 49.962

View more
  49 in total

1.  Microprocessor complex subunit DiGeorge syndrome critical region gene 8 (Dgcr8) is required for schwann cell myelination and myelin maintenance.

Authors:  Hsin-Pin Lin; Idil Oksuz; Edward Hurley; Lawrence Wrabetz; Rajeshwar Awatramani
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

2.  Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.

Authors:  Sophie Belin; Francesca Ornaghi; Ghjuvan'Ghjacumu Shackleford; Jie Wang; Cristina Scapin; Camila Lopez-Anido; Nicholas Silvestri; Neil Robertson; Courtney Williamson; Akihiro Ishii; Carla Taveggia; John Svaren; Rashmi Bansal; Markus H Schwab; Klaus Nave; Pietro Fratta; Maurizio D'Antonio; Yannick Poitelon; M Laura Feltri; Lawrence Wrabetz
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

3.  Regulation of Peripheral Nerve Myelin Maintenance by Gene Repression through Polycomb Repressive Complex 2.

Authors:  Ki H Ma; Holly A Hung; Rajini Srinivasan; Huafeng Xie; Stuart H Orkin; John Svaren
Journal:  J Neurosci       Date:  2015-06-03       Impact factor: 6.167

4.  Epigenomic Regulation of Schwann Cell Reprogramming in Peripheral Nerve Injury.

Authors:  Ki H Ma; Holly A Hung; John Svaren
Journal:  J Neurosci       Date:  2016-08-31       Impact factor: 6.167

5.  Schwann cell proliferation and differentiation that is induced by ferulic acid through MEK1/ERK1/2 signalling promotes peripheral nerve remyelination following crush injury in rats.

Authors:  Xiaoyan Zhu; Kun Li; Xin Guo; Jian Wang; Yang Xiang
Journal:  Exp Ther Med       Date:  2016-07-14       Impact factor: 2.447

6.  Dual specificity phosphatase 15 regulates Erk activation in Schwann cells.

Authors:  José F Rodríguez-Molina; Camila Lopez-Anido; Ki H Ma; Chongyu Zhang; Tyler Olson; Katharina N Muth; Matthias Weider; John Svaren
Journal:  J Neurochem       Date:  2017-01-09       Impact factor: 5.372

7.  Miz1 Controls Schwann Cell Proliferation via H3K36me2 Demethylase Kdm8 to Prevent Peripheral Nerve Demyelination.

Authors:  David Fuhrmann; Marco Mernberger; Andrea Nist; Thorsten Stiewe; Hans-Peter Elsässer
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

8.  Variation in SIPA1L2 is correlated with phenotype modification in Charcot- Marie- Tooth disease type 1A.

Authors:  Feifei Tao; Gary W Beecham; Adriana P Rebelo; John Svaren; Susan H Blanton; John J Moran; Camila Lopez-Anido; Jasper M Morrow; Lisa Abreu; Devon Rizzo; Callyn A Kirk; Xingyao Wu; Shawna Feely; Camiel Verhamme; Mario A Saporta; David N Herrmann; John W Day; Charlotte J Sumner; Thomas E Lloyd; Jun Li; Sabrina W Yum; Franco Taroni; Frank Baas; Byung-Ok Choi; Davide Pareyson; Steven S Scherer; Mary M Reilly; Michael E Shy; Stephan Züchner
Journal:  Ann Neurol       Date:  2019-03       Impact factor: 10.422

9.  SCY1-Like 1-Binding Protein 1 (SCYL1BP1) Suppressed Sciatic Nerve Regeneration by Enhancing the RhoA Pathway.

Authors:  Weidong Zhang; Yonghua Liu; Xudong Zhu; Yi Cao; Yang Liu; Xingxing Mao; Huiguang Yang; Zhengming Zhou; Youhua Wang; Aiguo Shen
Journal:  Mol Neurobiol       Date:  2015-11-16       Impact factor: 5.590

10.  Therapeutic Effect of Vinorine on Sciatic Nerve Injured Rat.

Authors:  Dongdong Guo; Xingang Lu; Xiaoli Xu; Haixin Gou; Zhiqian Wang; Yi Cao; Xingjing Luo
Journal:  Neurochem Res       Date:  2017-11-08       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.